Abstract
Antisense oligonucleotides are novel, highly selective inhibitors or modulators of gene expression. Attention is now being paid for the use of these agents not only in the treatment of genetic disorders but also for nongenetic disorders, where the treatment involves modulation of gene expression. However, antisense oligonucleotides face immense challenges for their use as therapeutics and successful application of these agents requires appropriate design and delivery strategies to increase their stability and intracellular uptake.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
